🇺🇸 MRK — Merck & Co., Inc.

Healthcare Compra
← Volver

Precio actual

150,33 USD

Máx. histórico

156,92

10 días

Split 1048:1000 del 03/06/2021

Caída desde máximo

-4,20%

Rango 52 semanas

77,58 – 156,92

Variación hoy

-1,32%

Cierre anterior

152,34

Rango de hoy

150,09 – 152,22

Volumen hoy

4.298.143

Información
Nombre completo
Merck & Co., Inc.
Divisa
USD
Mercado
NYSE
Sector
Healthcare
Industria
Drug Manufacturers - General
Empleados
73.000
PER ⓘ
120,26 (puede no estar actualizado)
Dividend yield
2,23% (puede no estar actualizado)
Precio objetivo analistas
149,50 USD (puede no estar actualizado)
Primera cotización
02/01/1962
Precio actualizado
hace 3 días
Sobre la empresa

Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.

Dividendos repartidos Total últimos 12 meses: 3,3600 USD · Yield: 2,24%
Fecha de pago Importe por participación
03/12/2003 0,3531 USD
03/09/2003 0,3531 USD
20/08/2003 2,7443 USD
04/06/2003 0,3435 USD
05/03/2003 0,3435 USD
04/12/2002 0,3435 USD
04/09/2002 0,3435 USD
05/06/2002 0,3340 USD
06/03/2002 0,3340 USD
05/12/2001 0,3340 USD
30/08/2001 0,3340 USD
31/05/2001 0,3244 USD
07/03/2001 0,3244 USD
06/12/2000 0,3244 USD
30/08/2000 0,3244 USD
Splits Registrados en el histórico de precios
Fecha Ratio
03/06/2021 1048:1000
17/02/1999 2:1
26/05/1992 3:1
26/05/1988 3:1
27/05/1986 2:1
01/06/1972 2:1
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
30/12/2011 35,87 36,14 35,75 35,97 -0,08% 1,06% 8.237.175
29/12/2011 35,88 36,02 35,77 36,00 +0,80% 0,69% 7.189.909
28/12/2011 35,96 36,07 35,69 35,72 -0,85% 1,06% 7.624.410
27/12/2011 36,05 36,16 35,98 36,02 -0,40% 0,50% 7.927.386
23/12/2011 35,95 36,16 35,92 36,16 +0,91% 0,69% 10.008.505
22/12/2011 35,67 36,02 35,51 35,84 +0,62% 1,44% 12.090.252
21/12/2011 35,36 35,70 35,32 35,62 +0,70% 1,05% 13.790.108
20/12/2011 35,04 35,45 34,83 35,37 +1,65% 1,77% 21.423.740
19/12/2011 34,76 35,11 34,68 34,80 +0,61% 1,26% 17.299.126
16/12/2011 34,83 34,94 34,37 34,59 -0,30% 1,64% 27.763.930
15/12/2011 34,27 35,00 34,25 34,69 +2,25% 2,20% 33.435.602
14/12/2011 33,33 34,12 33,30 33,93 +1,63% 2,46% 23.624.330
13/12/2011 33,61 33,74 33,26 33,39 -1,19% 1,42% 19.198.102
12/12/2011 33,95 34,04 33,57 33,79 -0,76% 1,38% 13.216.433
09/12/2011 33,69 34,22 33,60 34,05 +1,39% 1,84% 42.265.002
08/12/2011 34,04 34,09 33,46 33,58 -1,18% 1,85% 44.441.698
07/12/2011 33,66 34,14 33,59 33,98 +0,59% 1,64% 21.849.228
06/12/2011 33,81 33,97 33,64 33,78 +0,40% 0,99% 14.559.759
05/12/2011 34,14 34,22 33,45 33,65 -0,62% 2,24% 18.033.774
02/12/2011 34,27 34,27 33,75 33,86 -0,56% 1,50% 15.180.490
01/12/2011 34,09 34,34 33,93 34,05 -0,20% 1,20% 13.166.758
30/11/2011 33,59 34,16 33,59 34,11 +3,68% 1,70% 19.327.426
29/11/2011 32,92 33,31 32,80 32,90 +0,64% 1,57% 12.725.235
28/11/2011 32,19 32,74 32,15 32,69 +3,32% 1,84% 16.308.662
25/11/2011 31,77 31,87 31,61 31,64 -0,09% 0,81% 5.141.907
23/11/2011 31,91 32,03 31,67 31,67 -1,83% 1,14% 14.395.957
22/11/2011 32,53 32,65 32,21 32,26 -0,97% 1,35% 17.795.564
21/11/2011 32,81 32,98 32,44 32,58 -2,32% 1,63% 17.291.790
18/11/2011 33,34 33,61 33,34 33,35 +0,32% 0,80% 13.199.979
17/11/2011 33,32 33,57 32,84 33,24 -0,71% 2,18% 17.371.858